Burke Thomas Barrett

CEO

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€79k

▼ Sales (1 ops.)

€827k

Latest filing published 20 Dec 2024 for Pulse Biosciences, INC., €827k. Read the official filing

Filing timeline

BuySale

Burke Thomas Barrett

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Pulse Biosciences, INC. 1 purchase · last 22 May 2024

Since each purchase

Pulse Biosciences, Inc.
Filed 22 May 2024 · 879 days ago · €79k
+41.3%
Entry US$11.95 · Close at T+365 US$16.89

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Burke Thomas Barrett: trading record in brief

Burke Thomas Barrett appears in our data through filings on Pulse Biosciences, Inc. shares, published by SEC (Form 4). Between 20 May 2024 and 11 December 2024, the trades on record add up to 4 filings.

Both buying and selling appear: 1 purchase worth €79k, against 1 sale worth €827k. The net balance comes to €748k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.

Most recently, on 20 December 2024, the filings show an open-market sale worth €827k in Pulse Biosciences, Inc. The clock since the last published purchase (22 May 2024) now reads 879 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.